Literature DB >> 10446138

The adenovirus oncoprotein E1a stimulates binding of transcription factor ETF to transcriptionally activate the p53 gene.

T K Hale1, A W Braithwaite.   

Abstract

Expression of the tumor suppressor protein p53 plays an important role in regulating the cellular response to DNA damage. During adenovirus infection, levels of p53 protein also increase. It has been shown that this increase is due not only to increased stability of the p53 protein but to the transcriptional activation of the p53 gene during infection. We demonstrate here that the E1a proteins of adenovirus are responsible for activating the mouse p53 gene and that both major E1a proteins, 243R and 289R, are required for complete activation. E1a brings about the binding of two cellular transcription factors to the mouse p53 promoter. One of these, ETF, binds to three upstream sites in the p53 promoter and one downstream site, whereas E2F binds to one upstream site in the presence of E1a. Our studies indicate that E2F binding is not essential for activation of the p53 promoter but that ETF is. Our data indicate the ETF site located downstream of the start site of transcription is the key site in conferring E1a responsiveness on the p53 promoter.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446138     DOI: 10.1074/jbc.274.34.23777

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?

Authors:  B R Dix; S J Edwards; A W Braithwaite
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Toucan: deciphering the cis-regulatory logic of coregulated genes.

Authors:  Stein Aerts; Gert Thijs; Bert Coessens; Mik Staes; Yves Moreau; Bart De Moor
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

Review 3.  Adenoviral vectors for prodrug activation-based gene therapy for cancer.

Authors:  Joshua C Doloff; David J Waxman
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

4.  Adenovirus targets transcriptional and posttranslational mechanisms to limit gap junction function.

Authors:  Patrick J Calhoun; Allen V Phan; Jordan D Taylor; Carissa C James; Rachel L Padget; Michael J Zeitz; James W Smyth
Journal:  FASEB J       Date:  2020-06-02       Impact factor: 5.191

5.  Human telomerase reverse transcriptase promoter-driven oncolytic adenovirus with E1B-19 kDa and E1B-55 kDa gene deletions.

Authors:  Joshua C Doloff; David J Waxman; Youssef Jounaidi
Journal:  Hum Gene Ther       Date:  2008-12       Impact factor: 5.695

Review 6.  Conditionally replicating adenoviruses for cancer treatment.

Authors:  Youssef Jounaidi; Joshua C Doloff; David J Waxman
Journal:  Curr Cancer Drug Targets       Date:  2007-05       Impact factor: 3.428

7.  Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT.

Authors:  J C Doloff; Y Jounaidi; D J Waxman
Journal:  Cancer Gene Ther       Date:  2010-09-24       Impact factor: 5.987

8.  Offspring of mothers fed a high fat diet display hepatic cell cycle inhibition and associated changes in gene expression and DNA methylation.

Authors:  Kevin J Dudley; Deborah M Sloboda; Kristin L Connor; Jacques Beltrand; Mark H Vickers
Journal:  PLoS One       Date:  2011-07-11       Impact factor: 3.240

9.  A distance difference matrix approach to identifying transcription factors that regulate differential gene expression.

Authors:  Pieter De Bleser; Bart Hooghe; Dominique Vlieghe; Frans van Roy
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  TREMOR--a tool for retrieving transcriptional modules by incorporating motif covariance.

Authors:  Larry N Singh; Li-San Wang; Sridhar Hannenhalli
Journal:  Nucleic Acids Res       Date:  2007-10-25       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.